Danielle Antalffy
Stock Analyst at UBS
(3.63)
# 924
Out of 4,412 analysts
135
Total ratings
48.25%
Success rate
5.55%
Average return
Main Sectors:
36 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BSX Boston Scientific | Maintains: Buy | $74 → $90 | $73.17 | +23.00% | 8 | Apr 25, 2024 | |
| DXCM DexCom | Maintains: Buy | $153 → $163 | $124.34 | +31.09% | 7 | Apr 10, 2024 | |
| ATRC AtriCure | Maintains: Buy | $57 → $58 | $23.17 | +150.32% | 8 | Feb 16, 2024 | |
| INMD InMode | Maintains: Neutral | $24 → $26 | $17.14 | +51.69% | 3 | Feb 14, 2024 | |
| ENOV Enovis | Initiates: Buy | $75 | $55.26 | +35.72% | 1 | Jan 22, 2024 | |
| JNJ Johnson & Johnson | Upgrades: Buy | $180 | $146.14 | +23.17% | 4 | Dec 1, 2023 | |
| SYK Stryker | Maintains: Neutral | $289 → $297 | $335.61 | -11.50% | 3 | Nov 9, 2023 | |
| SWAV ShockWave Medical | Initiates: Neutral | $218 | $330.00 | -33.94% | 4 | Sep 29, 2023 | |
| TMCI Treace Medical Concepts | Initiates: Buy | $24 | $10.40 | +130.77% | 2 | Sep 29, 2023 | |
| INSP Inspire Medical Systems | Maintains: Buy | $405 → $322 | $237.45 | +35.61% | 5 | Sep 6, 2023 | |
| ABT Abbott Laboratories | Assumes: Buy | $117 | $107.53 | +8.81% | 10 | Mar 29, 2023 | |
| BFLY Butterfly Network | Initiates: Neutral | $2.25 | $0.78 | +188.91% | 1 | Mar 29, 2023 | |
| BAX Baxter International | Initiates: Neutral | $43 | $40.13 | +7.15% | 3 | Mar 29, 2023 | |
| ISRG Intuitive Surgical | Initiates: Neutral | $278 | $375.33 | -25.93% | 1 | Mar 29, 2023 | |
| TNDM Tandem Diabetes Care | Initiates: Neutral | $45 | $35.24 | +27.70% | 9 | Mar 29, 2023 | |
| EW Edwards Lifesciences | Initiates: Neutral | $84 | $86.43 | -2.81% | 9 | Mar 29, 2023 | |
| ZBH Zimmer Biomet Holdings | Initiates: Sell | $112 | $119.35 | -6.16% | 3 | Mar 29, 2023 | |
| UTRS Minerva Surgical | Maintains: Outperform | $160 → $140 | $0.00 | +13,999,900.00% | 3 | May 12, 2022 | |
| RXST RxSight | Maintains: Outperform | $16 → $14 | $52.77 | -73.47% | 1 | May 6, 2022 | |
| PODD Insulet | Maintains: Outperform | $300 → $280 | $166.19 | +68.48% | 8 | May 6, 2022 | |
| OM Outset Medical | Maintains: Outperform | $65 → $55 | $2.40 | +2,191.67% | 2 | May 5, 2022 | |
| AXGN AxoGen | Maintains: Outperform | $12 → $14 | $6.63 | +111.16% | 1 | May 5, 2022 | |
| LNTH Lantheus Holdings | Maintains: Outperform | $75 → $100 | $65.56 | +52.53% | 2 | May 2, 2022 | |
| NPCE NeuroPace | Maintains: Outperform | $15 → $12 | $13.39 | -10.38% | 3 | Mar 11, 2022 | |
| PRCT PROCEPT BioRobotics | Maintains: Outperform | $25 → $30 | $51.83 | -42.12% | 2 | Mar 9, 2022 | |
| AXNX Axonics | Maintains: Outperform | $60 → $65 | $66.69 | -2.53% | 3 | Feb 25, 2022 | |
| VCEL Vericel | Maintains: Outperform | $40 → $45 | $46.05 | -2.28% | 3 | Feb 25, 2022 | |
| NVRO Nevro | Maintains: Outperform | $105 → $85 | $11.32 | +650.88% | 6 | Feb 24, 2022 | |
| NARI Inari Medical | Maintains: Outperform | $85 → $95 | $38.42 | +147.27% | 5 | Feb 24, 2022 | |
| BDX Becton, Dickinson and Company | Maintains: Market Perform | $270 → $275 | $231.55 | +18.76% | 1 | Feb 4, 2022 | |
| MDT Medtronic | Maintains: Market Perform | $138 → $115 | $79.74 | +44.22% | 6 | Jan 21, 2022 | |
| ORGO Organogenesis Holdings | Maintains: Outperform | n/a | $2.35 | - | 1 | Nov 10, 2021 | |
| SILK Silk Road Medical | Maintains: Outperform | n/a | $17.80 | - | 1 | Nov 10, 2021 | |
| INGN Inogen | Maintains: Market Perform | n/a | $6.78 | - | 3 | Nov 5, 2021 | |
| SENS Senseonics Holdings | Downgrades: Market Perform | n/a | $0.42 | - | 2 | Apr 1, 2021 | |
| CTSO Cytosorbents | Initiates: Outperform | n/a | $0.82 | - | 1 | Sep 1, 2020 |
Boston Scientific
Apr 25, 2024
Maintains: Buy
Price Target: $74 → $90
Current: $73.17
Upside: +23.00%
DexCom
Apr 10, 2024
Maintains: Buy
Price Target: $153 → $163
Current: $124.34
Upside: +31.09%
AtriCure
Feb 16, 2024
Maintains: Buy
Price Target: $57 → $58
Current: $23.17
Upside: +150.32%
InMode
Feb 14, 2024
Maintains: Neutral
Price Target: $24 → $26
Current: $17.14
Upside: +51.69%
Enovis
Jan 22, 2024
Initiates: Buy
Price Target: $75
Current: $55.26
Upside: +35.72%
Johnson & Johnson
Dec 1, 2023
Upgrades: Buy
Price Target: $180
Current: $146.14
Upside: +23.17%
Stryker
Nov 9, 2023
Maintains: Neutral
Price Target: $289 → $297
Current: $335.61
Upside: -11.50%
ShockWave Medical
Sep 29, 2023
Initiates: Neutral
Price Target: $218
Current: $330.00
Upside: -33.94%
Treace Medical Concepts
Sep 29, 2023
Initiates: Buy
Price Target: $24
Current: $10.40
Upside: +130.77%
Inspire Medical Systems
Sep 6, 2023
Maintains: Buy
Price Target: $405 → $322
Current: $237.45
Upside: +35.61%
Abbott Laboratories
Mar 29, 2023
Assumes: Buy
Price Target: $117
Current: $107.53
Upside: +8.81%
Butterfly Network
Mar 29, 2023
Initiates: Neutral
Price Target: $2.25
Current: $0.78
Upside: +188.91%
Baxter International
Mar 29, 2023
Initiates: Neutral
Price Target: $43
Current: $40.13
Upside: +7.15%
Intuitive Surgical
Mar 29, 2023
Initiates: Neutral
Price Target: $278
Current: $375.33
Upside: -25.93%
Tandem Diabetes Care
Mar 29, 2023
Initiates: Neutral
Price Target: $45
Current: $35.24
Upside: +27.70%
Edwards Lifesciences
Mar 29, 2023
Initiates: Neutral
Price Target: $84
Current: $86.43
Upside: -2.81%
Zimmer Biomet Holdings
Mar 29, 2023
Initiates: Sell
Price Target: $112
Current: $119.35
Upside: -6.16%
Minerva Surgical
May 12, 2022
Maintains: Outperform
Price Target: $160 → $140
Current: $0.00
Upside: +13,999,900.00%
RxSight
May 6, 2022
Maintains: Outperform
Price Target: $16 → $14
Current: $52.77
Upside: -73.47%
Insulet
May 6, 2022
Maintains: Outperform
Price Target: $300 → $280
Current: $166.19
Upside: +68.48%
Outset Medical
May 5, 2022
Maintains: Outperform
Price Target: $65 → $55
Current: $2.40
Upside: +2,191.67%
AxoGen
May 5, 2022
Maintains: Outperform
Price Target: $12 → $14
Current: $6.63
Upside: +111.16%
Lantheus Holdings
May 2, 2022
Maintains: Outperform
Price Target: $75 → $100
Current: $65.56
Upside: +52.53%
NeuroPace
Mar 11, 2022
Maintains: Outperform
Price Target: $15 → $12
Current: $13.39
Upside: -10.38%
PROCEPT BioRobotics
Mar 9, 2022
Maintains: Outperform
Price Target: $25 → $30
Current: $51.83
Upside: -42.12%
Axonics
Feb 25, 2022
Maintains: Outperform
Price Target: $60 → $65
Current: $66.69
Upside: -2.53%
Vericel
Feb 25, 2022
Maintains: Outperform
Price Target: $40 → $45
Current: $46.05
Upside: -2.28%
Nevro
Feb 24, 2022
Maintains: Outperform
Price Target: $105 → $85
Current: $11.32
Upside: +650.88%
Inari Medical
Feb 24, 2022
Maintains: Outperform
Price Target: $85 → $95
Current: $38.42
Upside: +147.27%
Becton, Dickinson and Company
Feb 4, 2022
Maintains: Market Perform
Price Target: $270 → $275
Current: $231.55
Upside: +18.76%
Medtronic
Jan 21, 2022
Maintains: Market Perform
Price Target: $138 → $115
Current: $79.74
Upside: +44.22%
Organogenesis Holdings
Nov 10, 2021
Maintains: Outperform
Price Target: n/a
Current: $2.35
Upside: -
Silk Road Medical
Nov 10, 2021
Maintains: Outperform
Price Target: n/a
Current: $17.80
Upside: -
Inogen
Nov 5, 2021
Maintains: Market Perform
Price Target: n/a
Current: $6.78
Upside: -
Senseonics Holdings
Apr 1, 2021
Downgrades: Market Perform
Price Target: n/a
Current: $0.42
Upside: -
Cytosorbents
Sep 1, 2020
Initiates: Outperform
Price Target: n/a
Current: $0.82
Upside: -